Rosiglitazone influences adipose tissue distribution without deleterious impact on heart rate variability in coronary heart disease patients with type 2 diabetes
Crossref DOI link: https://doi.org/10.1007/s10286-016-0373-7
Published Online: 2016-08-06
Published Print: 2016-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Grenier, Audrey
Brassard, Patrice
Bertrand, Olivier F.
Després, Jean-Pierre
Costerousse, Olivier
Alméras, Natalie
Poirier, et Paul
License valid from 2016-08-06